BONNEY MICHAEL W — SEC Form 4 filings
SEC reporting owner CIK 1219016. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-05-20 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 15 legs across 2 filings — 22,500 shares, $8,186,717 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 11,250 shares @ $450.00 ($5,062,500) in ALNYLAM PHARMACEUTICALS, INC., filed 2025-08-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | 4 | — | 15 legs · 22,500 sh · $8,186,717 | 7 |
| Autolus Therapeutics plc (AUTL) | Director | 1 | — | — | 2 |
| IMMUNIC, INC. (IMUX) | Director | 1 | — | — | 1 |
Form 4 filings — BONNEY MICHAEL W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Autolus Therapeutics plc (AUTL) | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | IMMUNIC, INC. (IMUX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Option exercise (M): 11,250 @ $70.20 · Sale (S): 11,250 @ $450 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Option exercise (M): 11,250 @ $131.21 · Sale (S): 549 @ $267.14 · Sale (S): 729 @ $268.56 · Sale (S): 245 @ $269.79 · Sale (S): 431 @ $271.68 · Sale (S): 660 @ $273.16 · +10 more | EDGAR |
| 2025-05-12 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 775 @ $0 · Grant/award (A): 1,558 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 5,228 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1219016 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →